PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A statement from the Global Virus Network (GVN) on the rapidly escalating measles crisis in the U.S. and worldwide

GVN urges immediate action to reverse declining immunization rates amid largest U.S. measles surge in decades

2025-07-16
(Press-News.org) Tampa, FL, USA - The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and Affiliates in more than 40 countries, is sounding the alarm over a sharp resurgence of measles cases in the United States and globally. This resurgence, fueled by falling vaccination rates, threatens to erode decades of public health progress.

Measles is one of the most contagious viruses known to humans and is entirely preventable through routine vaccination. The U.S. is now experiencing its highest number of measles cases in over 30 years, with nearly 1300 confirmed cases reported across nearly 40 states in 2025 alone. A recent outbreak in Texas, its largest since the 1990s, has resulted in the death of two children and hundreds of cases concentrated in areas with low vaccine coverage, such as Gaines County. According to publicly available data, the percentage of K–12 students in Gaines County with a conscientious exemption to at least one vaccine has generally increased over the past decade, rising from 4.83% in the 2015–2016 school year to 14.54% in 2024–2025. While some fluctuations in the percentages were reported, the overall trend shows a significant rise, particularly in recent years.

Additional clusters have been confirmed in New Mexico, Kansas, California, Ohio, Pennsylvania, Montana, and Kentucky, among others. These outbreaks underscore how quickly the virus can spread, especially among unvaccinated children. The U.S. Centers for Disease Control and Prevention (CDC) reports that kindergarten vaccination rates have dropped below 93% nationally during the 2023-2024 school year, while nonmedical exemptions have climbed to a record 3.3%. These figures are below the 95% threshold needed for levels of herd immunity to prevent outbreaks.

Globally, measles is surging in Africa, Southeast Asia, and Europe, exacerbated by war, displacement, fragile health systems, and interrupted vaccination campaigns. The World Health Organization (WHO) and the CDC report that over 10.3 million cases occurred worldwide in 2023, up from just 10,000 in 2022, a 30-fold increase.

Half of all large outbreaks occurred in Africa, with significant upswings in Europe, where 41 of 53 countries reported measles cases.  The Americas reported an 11-fold increase in early 2025 measles cases, many of them imported by travelers returning from high-incidence regions.

“As global travel rebounds, localized outbreaks can quickly become international threats,” said Robert C. Gallo, MD, chairman of the Scientific Leadership Board and co-founder of the GVN. “This is not just about measles, it’s a warning about what happens when we let our guard down against vaccine-preventable diseases.” Dr. Gallo, who is most widely known for his co-discovery of HIV as the cause of AIDS, is also the James P. Cullison Professor of Medicine and director of the Institute of Translational Virology and Innovation at the University of South Florida Morsani College of Medicine, and director of the Microbial Oncology Program at Tampa General Hospital (TGH) Cancer Institute.

Complications from measles are not rare. In unvaccinated populations, 1 to 3 in 1,000 infected children die, while many more suffer from pneumonia, severe diarrhea, deafness, or encephalitis. Some children go on to develop subacute sclerosing panencephalitis, a deadly neurologic condition that can appear years after infection.

“Every measles outbreak is a failure of public health infrastructure and public trust,” said Scott C. Weaver, MS, PhD, GVN Center of Excellence Director at The University of Texas Medical Branch and Scientific Director of the Galveston National Laboratory. “We cannot afford complacency. The MMR vaccine is safe, effective, and essential to safeguarding our communities, especially the most vulnerable among us.”

The GVN urgently calls for:

Immediate vaccination of unvaccinated children and adults with the MMR vaccine. Stronger public health messaging. Improved outbreak surveillance and response systems at local, national, and global levels. Focused efforts in underserved and rural communities, where access and hesitancy pose heightened risks. As a network dedicated to pandemic preparedness, the GVN warns that the erosion of routine immunization not only endangers individual lives but also undermines global capacity to respond to future viral threats.

GVN experts are available for interviews and commentary.

###

About the Global Virus Network (GVN)
The Global Virus Network (GVN) is a worldwide coalition comprising 80+ Virology Centers of Excellence and Affiliates across 40+ countries, whose mission is to facilitate pandemic preparedness against viral pathogens and diseases that threaten public health globally. GVN advances knowledge of viruses through (i) data-driven research and solutions, (ii) fostering the next generation of virology leaders, and (iii) enhancing global resources for readiness and response to emerging viral threats. GVN provides the essential expertise required to discover and diagnose viruses that threaten public health, understand how such viruses spread illnesses, and facilitate the development of diagnostics, therapies, and treatments to combat them. GVN coordinates and collaborates with local, national, and international scientific institutions and government agencies to provide real-time virus informatics, surveillance, and response resources and strategies.  GVN's pandemic preparedness mission is achieved by focusing on Education & Training, Qualitative & Quantitative Research, and Global Health Strategies & Solutions. The GVN is a non-profit 501(c)(3) organization. For more information, please visit www.gvn.org.

Media Contact:
Nora Samaranayake
nsamaranayake@gvn.org

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Restored wetlands reap benefits for climate, drought-resilience after just one year: study

2025-07-16
Reviving floodplain wetlands slashes carbon emissions by 39% and restores critical ecosystem functions in one year – without the methane spike typically seen in restored peatlands, a new study has found. Peatlands are known as top carbon sinks, but can produce up to 530% more methane after restoration, potentially offsetting short-term climate benefits. Whereas floodplain, or riparian wetlands, which comprise over half of global wetlands, are often overlooked due to their lower carbon storage. Now a new study in the Journal of Environmental ...

PPPL’s Jack Berkery receives Fulbright Specialist award to share research on spherical tokamaks

2025-07-16
In a field where collaboration is key to progress, Jack Berkery, a leader in U.S. fusion research, is heading to Japan as a Fulbright Specialist to help strengthen the ties that power the future of fusion energy. Berkery is the deputy director of the National Spherical Torus Experiment-Upgrade (NSTX-U) at the U.S. Department of Energy’s Princeton Plasma Physics Laboratory (PPPL). The Fulbright Specialist Program pairs specialists with select host institutions to build international partnerships.  Berkery’s two-week visit to Japan will include meetings with researchers at Kyushu University and participation ...

Survey shows GLP-1 weight-loss drugs are changing sex and dating for 50-60% of users

2025-07-16
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S. adults (ages 18 to 91) led by the Kinsey Institute at Indiana University with DatingNews.com, GLP-1 users reported a wide range of physical, social, and psychological shifts they attributed to the drug. Among respondents, 8% reported having used a GLP-1 medication to assist with weight loss, with no significant difference difference in use between men and women. Among GLP-1 users, 59% reported at least one impact of the drug on their dating life including: 17% ...

Dr. Jennifer Ashton and Dr. Joseph Woo join American Heart Association Board of Directors

2025-07-16
DALLAS, July 16, 2025 — The American Heart Association, the world’s leading nonprofit organization focused on heart and brain health for all, announces the appointment of two leading health and science leaders, Jennifer Ashton, M.D., M.S. and Joseph Woo, M.D., FAHA, to its volunteer Board of Directors, effective July 1, 2025. Dr. Ashton and Dr. Woo bring clinical leadership, health media influence and scientific innovation to the Association as it enters its second century, intensifying its efforts to change ...

Can legal obstacles delay Japan’s plans to achieve carbon neutrality?

2025-07-16
Japan’s green transformation (GX) strategy aims to achieve carbon neutrality by 2050 through growth-oriented carbon pricing, but some parties face litigations against renewable energy projects. A recent study analyzed Japan’s GX Promotion Act and compared it to the United States’ clean energy policies, including both successes and setbacks. The findings stress that early stakeholder involvement and cooperation with local communities are essential for successful renewable energy projects and a seamless green transition. As nations worldwide race to ...

Drexel engineers want to make buildings more energy efficient by making walls, floors and ceilings more like elephant ears

2025-07-16
Drawing inspiration from the veinous ears of jackrabbits and elephants, Drexel University researchers have come up with a new approach to passive heating and cooling that could one day make buildings more energy efficient. Their concept, recently published in the Journal of Building Engineering, embeds a vascular network within cement-based building materials that, when filled with paraffin-based material, can help passively regulate the surface temperature of walls, floors and ceilings. The approach is an effort to address the substantial contribution of building energy demand — nearly 40% of all energy use — to the production of greenhouse gas. ...

Teams engineer microporous new CO₂-activated carbon material—Enabling energy-efficient separation of critical fluorinated gases

2025-07-16
Ultramicroporous carbon materials with Ångstrom-precise pore engineering offer a transformative solution for separating fluorinated gases like C3F6 (fluorinated propylene) and C3F8 (fluorinated propane). A team of scientists has synthesized the CO2-activated porous carbon adsorbents derived from a precursory resin and systematically investigated their molecular sieving behavior for C3F6/C3F8 mixtures. Through controlled thermal pyrolysis and stepwise CO2 activation, they tailored ultramicropore size distributions to selectively exclude or admit target molecules. Their work is published in the journal Industrial Chemistry & ...

TTUHSC’s Logsdon receives grant to study vascular side of traumatic brain injuries

2025-07-16
Each year in the U.S., approximately 2.5 million people suffer traumatic brain injuries (TBIs). About 50,000 of these injuries will result in death, and more than 80,000 will lead to permanent disability. TBI is a chronic health condition and appears to be a notable risk factor for developing age-related cognitive impairment through converging biological mechanisms that are poorly understood.  Aric F. Logsdon, Ph.D., from the Department of Pharmacology and Neuroscience at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, said people with a history of TBI often present with vascular dysfunctions that are associated with age-related diseases. The pathophysiological ...

Pusan National University researchers develop game-changing method to create safer, long-lasting lithium-ion batteries

2025-07-16
With the recent global push toward renewable energy and electric vehicles, the demand for lithium-ion batteries (LIBs) is rising rapidly. The performance and stability of LIBs largely depend on the cathode material, which can account for nearly 40–45% of the total battery cost. Among cutting-edge technologies, high-nickel cathodes stand out for their high energy density and cost efficiency. However, increasing the nickel content also intensifies side reactions, severely compromising interfacial robustness and mechanical integrity—factors that limit large-scale applications. A promising solution is the use of full concentration gradient ...

Scientists uncover key to stable, high-performance, and long-life sodium-ion batteries

2025-07-16
Sodium (Na)-ion batteries have recently emerged as cost-effective and sustainable alternatives to lithium (Li)-ion batteries. Na, the sixth most abundant element on Earth, offers lower material costs and greater availability compared to Li-ion batteries. The design of cathode materials plays a key role in determining battery life and stability. Layered sodium manganese oxide (NaMnO2) has received increased attention from researchers for its use as a  cathode material in Na-ion batteries. NaMnO2 exists in two crystal forms: α-NaMnO2 and β-NaMnO2. The α-phase features a monoclinic layered structure, where planar MnO2 layers, consisting of edge-sharing distorted ...

LAST 30 PRESS RELEASES:

Scientists uncover key to decoupling economic growth from pollution in developing countries

Frailty fuels gut imbalance and post-surgery gastrointestinal risks

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

[Press-News.org] A statement from the Global Virus Network (GVN) on the rapidly escalating measles crisis in the U.S. and worldwide
GVN urges immediate action to reverse declining immunization rates amid largest U.S. measles surge in decades